Experimental Procedures Sample Clauses
The Experimental Procedures clause defines the methods and protocols to be followed during the conduct of experiments under an agreement. It typically outlines the specific steps, materials, and conditions required for the research, ensuring that all parties adhere to a consistent and agreed-upon process. By clearly specifying how experiments should be performed, this clause helps maintain scientific integrity, reproducibility, and compliance with regulatory or safety standards.
POPULAR SAMPLE Copied 1 times
Experimental Procedures. Sellers have not performed or permitted the performance of any experimental or research procedures or studies involving patients of the Hospital not authorized and conducted in accordance with applicable law and the procedures of the Institutional Review Board of the Hospital.
Experimental Procedures. During the past five (5) years Seller has not performed or permitted the performance of any Experimental Procedures involving patients in the Healthcare Facilities not authorized and conducted in accordance with the procedures of the applicable Institutional Review Board.
Experimental Procedures. No Seller has performed or authorized the performance of any experimental or research procedures or studies involving patients of any Facility that require the prior approval of any governmental entity that has not been obtained.
Experimental Procedures. The Partnership has not performed or permitted the performance of any experimental or research procedures or studies involving patients of the Hospital not authorized and conducted in accordance with the procedures of the Institutional Review Board of the Hospital.
Experimental Procedures. The study protocol was approved by the University of California, Berkeley Committee for Protection of Human Subjects, following the declaration of Helsinki. All partici- pants gave written informed consent after the nature of Patient Lesion volume (cm3) % STG and MTG % AG and SMG % LIFG P1 18.32 26.9 7.4 0 P2 4.51 5.6 0 0 P3 93.75 62.3 48 0 P4 36.95 45.5 0 0 P5 103.17 22.7 21.7 21.4 P6 85.82 84.5 43.1 0 Mean (sd) 57.08 (38.68) 41.25 (28.82) 20 (21.4) 3.57 (8.74)
Experimental Procedures. The Seller Entities have not performed or permitted the performance of any experimental or research procedures or studies involving patients of the Hospital not authorized and conducted in accordance with the procedures of the Institutional Review Board of the Hospital. All human subject research (as that phrase is defined by federal Law), or research governed by the federal Animal Welfare Act, involving the Seller Entities is identified on Schedule 3.23.
Experimental Procedures. To Seller’s and Parent’s Knowledge, the performance of any experimental or research procedures or studies involving patients in the Company or any of the Facilities has complied with all Legal Requirements in all material respects. Any exception to the representations and warranties contained in this Section 5.27 shall be disclosed on the attached Schedule 5.27.
Experimental Procedures. Expression constructs and antibodies Yeast two-hybrid screen Western blot analysis Immunofluorescence microscopy Immunohistochemistry Co-immunoprecipitation Subcellular fractionation Opti-prep gradient fractionation Quantitative analysis of the NE/ER distribution Quantitative analysis of co-localization
Experimental Procedures. No Seller has performed or permitted the performance of any experimental or research procedures or studies involving residents of the Business.
Experimental Procedures. During the past five (5) years, neither Sellers, the Mission Acquired Entities, the Material Joint Venture Provider Entities, the Facilities nor the Material Joint Venture Provider Facilities have performed or permitted the performance of any experimental or research procedure or study involving patients in the Facilities or the Material Joint Venture Provider Facilities that were not authorized and/or conducted in accordance with the policies and procedures of the Facilities or the Material Joint Venture Provider Facilities that comply in all material respects with applicable Laws, including applicable U.S. Food and Drug Administration regulations.